-
Deutsche Bank Has Buy On Medtronic (MDT)
Thursday, March 10, 2011 - 8:34am | 289Deutsche Bank has a Buy rating and a $46 price target on shares of Medtronic (NYSE: MDT). In a note to clients, Deutsche Bank writes, "While we are hopeful too that it will be approved given a somewhat favorable FDA panel review, it now seems less likely to be in the near-term. The absence of...
-
Orthofix International Promotes Brian McCollum to Chief Financial Officer
Wednesday, March 9, 2011 - 11:15am | 61Orthofix International N.V. (NASDAQ: OFIX) today announced that effective March 1, 2011, Brian McCollum has been promoted to Chief Financial Officer. Mr. McCollum had been serving as the Company's Interim Chief Financial Officer since January 2011. Mr. McCollum has been with the Company for close...
-
Top Narrow Based Indexes For March 9 (NGLPF, COOL, CMN)
Wednesday, March 9, 2011 - 11:00am | 197By 10:00 am, the Dow Jones Industrial Average was down 25.31 points, or 0.21%, to 12,189.07, while the broader Standard & Poor's 500 index had fallen 5.38 points, or 0.41%. The NASDAQ composite index dropped 17.44 points, or 0.63%. Some of the narrow based indexes that are still afloat in the...
-
Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit
Wednesday, March 9, 2011 - 10:52am | 111Salient Surgical Technologies, Inc., a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, announced today a settlement in the Company's patent infringement lawsuit against Bovie® Medical (NYSE: BVX). Under the terms of the...
-
Hospira Announces U.S. Approval of Generic Docetaxel
Wednesday, March 9, 2011 - 10:46am | 53Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere®, and Hospira expects to launch the product later this month.
-
Medtronic Resolves FDA Warning Letters
Wednesday, March 9, 2011 - 10:06am | 66Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters -- one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's...
-
Earnings Scheduled For March 9 (PLCE, BONT, JAS, MW, CWTR, HRB, KFY, AEO, IDSY, CMN, AIQ, BBEP, SIGA)
Wednesday, March 9, 2011 - 3:48am | 384Children's Place Retail Stores Inc (NASDAQ: PLCE) is projected to report its Q4 EPS at $1.01 on revenue of $468.54 million. Bon-Ton Stores Inc (NASDAQ: BONT) is expected to report its Q4 EPS at $4.30 on revenue of $1.02 billion. Jo-Ann Stores Inc (NYSE: JAS) is estimated to report its Q4 EPS at...
-
Stryker Corp. Director Sells 27,000 Shares of SYK
Tuesday, March 8, 2011 - 6:28pm | 70In a Form 4 filed earlier today, Stryker Corp. (NYSE: SYK) Director, Ronda Stryker, reported that she sold 27,000 shares of SYK on March 4th-8th for an average price of $63.71. The transaction totaled $1,720,186. This sale was 10b5-1 Plan indicated. Ms. Stryker owns 132,000 direct shares and 33,...
-
Orthovita Reports Q4 EPS of $(0.05) vs. $0.00
Tuesday, March 8, 2011 - 5:45pm | 145Orthovita, Inc. (NASDAQ: VITA), reported financial results for the quarter and year ended December 31, 2010. Product sales for the quarter ended December 31, 2010 decreased 4% to $23.4 million compared to $24.4 million for the same period in 2009. Product sales for the year ended December 31, 2010...
-
K-V Pharmaceuticals Adds Another 27% (KV.A)
Tuesday, March 8, 2011 - 3:09pm | 248K-V Pharmaceuticals (NYSE:KV.A) is probably the hottest stock on the planet right now. The shares have added another 27% on Tuesday, and the company now has a market cap of $634.72 million. Year-to-date, the stock is up around 400%. The catalyst for the move in the shares was the FDA approval of...
-
Invacare Buys 350K Shares From Chairman At $29.94/Share (IVC)
Tuesday, March 8, 2011 - 10:13am | 315Invacare (NYSE: IVC) today disclosed that the company bought 350K common shares at $29.94/share from from company's co-executive Chairman, Mal Mixon. On March 7, 2011, Invacare Corporation, based upon the authorization and approval of the Company's Board of Directors and a Special Committee of the...
-
Forest Laboratories Commences Tender Offer for Shares and Certain Notes and Warrants of Clinical Data, Inc.
Tuesday, March 8, 2011 - 9:34am | 184Forest Laboratories, Inc. (NYSE: FRX) today announced the commencement of a tender offer by its indirect wholly-owned subsidiary, Magnolia Acquisition Corp., for all outstanding shares of common stock, $0.01 par value, of Clinical Data, Inc. (NASDAQ: CLDA) for $30.00 per share in cash plus...
-
Goldman Sachs Maintains Buy Rating On Hospira
Tuesday, March 8, 2011 - 9:33am | 167In a report published by Goldman Sachs, Hospira (NYSE: HSP) has a new CEO in place, with fundamental catalysts up next. Goldman Sachs said that, in addition to the company's appointment of Michael Ball (currently President of Allergan) to the CEO role, it sees two upcoming fundamental catalysts...
-
Market Share Implications of Accuracy's TomoTherapy Acquisition (ARAY)
Monday, March 7, 2011 - 2:50pm | 209Citi released a report today which discusses the implications of Accuracy's (NASDAQ: ARAY) acquisition of TomoTherapy (NASDAQ: TOMO) and its effects on Varian Medical Systems' (NYSE: VAR) market share. While the deal will allow ARAY to expand from radiosurgery into radiotherapy, Citi analysts do...
-
NASDAQ Stocks Hitting 52-Week Highs (VRUS, TOMO, SYMX, OVTI)
Monday, March 7, 2011 - 11:53am | 172Pharmasset Inc (NASDAQ: VRUS) shares rose 6.83% to create a new 52-week high of $53.17. VRUS shares have jumped 130.84% over the past 52 weeks, while the S&P 500 index has gained 16.02% in the same period. TomoTherapy Incorporated (NASDAQ: TOMO) shares gained 25.61% to create a new 52-week...